創傷ケア用生物製剤の世界市場予測(~2023年):生物学的代用皮膚(生合成製品)、外用剤

◆英語タイトル:Wound Care Biologics Market by Product (Biological Skin Substitutes (Biosynthetic Products), Topical Agents), Wound Type (Diabetic Foot Ulcer, Pressure Ulcers, Surgical & Traumatic Wound), End User (Hospitals, Burn Centers) - Global Forecast to 2023
◆商品コード:MD-6335
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2018年6月1日
◆ページ数:125
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。

MarketsandMarketsが発行した当調査レポートでは、創傷ケア用生物製剤の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品(生物学的代用皮膚(生合成製品)、外用剤)別分析、創傷種類別分析、需要先別分析、地域別分析、創傷ケア用生物製剤の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

・イントロダクション
・エグゼクティブサマリー
・創傷ケア用生物製剤の世界市場:市場インサイト
・創傷ケア用生物製剤の世界市場:市場概観/市場動向
・創傷ケア用生物製剤の世界市場:市場シェア分析
・創傷ケア用生物製剤の世界市場:製品(生物学的代用皮膚(生合成製品)、外用剤)別分析/市場規模
・創傷ケア用生物製剤の世界市場:創傷種類別分析/市場規模
・創傷ケア用生物製剤の世界市場:需要先別分析/市場規模
・創傷ケア用生物製剤の世界市場:地域別分析/市場規模
・創傷ケア用生物製剤のアジア市場規模予測
・創傷ケア用生物製剤のヨーロッパ市場規模予測
・創傷ケア用生物製剤のアメリカ市場規模予測
・創傷ケア用生物製剤の世界市場動向
・創傷ケア用生物製剤の世界市場:競争状況
・創傷ケア用生物製剤の世界市場:関連企業分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

The global wound care biologics market is expected to reach USD 2.26 Billion by 2023 from USD 1.42 Billion in 2018, at a CAGR of 9.8%. Market growth is mainly driven by factors such as the increasing incidence of diabetic foot ulcers, increasing geriatric population, and increasing burn injuries globally. On the other hand, the high cost of wound care biologics and the higher rejection rate associated with skin grafts & substitutes will restrain the growth of this market.
The global wound care biologics market is segmented on the basis of product, wound type, end user, and region. By product, the wound care biologics market segmented into biological skin substitutes and topical agents. The biological skin substitutes segment is estimated to account for the largest share of the market in 2018. The rising incidence of hard-to-heal wounds and their growing adoption (due to their high efficacy) are driving the growth of this product segment. The biological skin substitutes segment is further categorized into human donor tissue-derived products, acellular animal-derived products, and biosynthetic products.

On the basis of wound type, the wound care biologics market is segmented into ulcers, surgical & traumatic wounds, and burns. In 2018, the ulcers segment is expected to account for the largest share of the wound care biologics market. Market growth can primarily be attributed to the widespread adoption of wound care biologics for the treatment of ulcers and burn injuries in developed countries and the high incidence rate of diabetic foot ulcers.

On the basis of end user, the wound care biologics market is segmented into hospitals, ASCs, and burn centers & wound clinics. In 2017, the hospitals segment accounted for the largest share of the market. Hospitals are the largest end users of wound care biologics, as most of the wound care treatment using biologics are conducted in hospital settings.

Wound Care Biologics Market

On the basis of region, the wound care biologics market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America is expected to command the largest share of the wound care biologics market. The large share of this segment can primarily be attributed to the high presence of key players in this region, the availability of a variety of wound biologics products, and the high prevalence of diabetic foot ulcers this region.

However, the Asia Pacific market is estimated to register the highest growth during the forecast period primarily due to the presence of a large patient population, increasing penetration of key market players, and the large number of research and development activities for wound care biologic products.

Some of the major players in the wound care biologics market are Smith & Nephew (UK), Mölnlycke Health Care AB (Sweden), Integra LifeSciences Corporation (US), Wright Medical (US), MiMedx Group (US), Vericel Corporation (US), Anika Therapeutics (US), Osiris Therapeutics (US), Organogenesis (US), Kerecis (Iceland), Solsys Medical (US), ACell (US), Lavior Inc. (US), and Marine Polymer Technologies, Inc. (US). These companies have products for all end users in this market, a strong geographical presence, and a focus on continuous product innovation.

【レポートの目次】

1 Introduction (Page No. – 12)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 15)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 23)

4 Premium Insights (Page No. – 26)
4.1 Wound Care Biologics Market Overview
4.2 Geographic Analysis: Wound Care Biologics Market, By Product (2018)
4.3 Geographic Snapshot of the Wound Care Biologics Market
4.4 Wound Care Biologics Market, By Wound Type

5 Market Overview (Page No. – 30)
5.1 Introduction
5.2 Reimbursement Scenario for Skin Substitutes in the US
5.2.1 General Criteria Covered
5.2.2 Apligraf, Theraskin, and Epifix
5.2.3 Dermagraft
5.2.4 Integra
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Rising Incidences of Burn Injuries
5.3.1.2 Rapid Growth in the Geriatric Population
5.3.1.3 Growing Incidence of Ulcers and Target Conditions
5.3.1.4 Innovation in Wound Care Biologics
5.3.1.5 Awareness Programs for Wound Care Treatment and Management
5.3.2 Market Restraints
5.3.2.1 High Cost of Wound Treatment and Wound Care Biologics
5.3.2.2 Risk of Skin Substitute Failure
5.3.3 Market Opportunities
5.3.3.1 Increasing Research on Advanced Wound Treatments
5.3.3.2 3d Skin Printing

6 Wound Care Biologics Market, By Product (Page No. – 39)
6.1 Introduction
6.2 Biological Skin Substitutes
6.2.1 Human Donor Tissue-Derived Products
6.2.2 Acellular Animal-Derived Products
6.2.3 Biosynthetic Products
6.3 Topical Agents

7 Wound Care Biologics Market, By Wound Type (Page No. – 46)
7.1 Introduction
7.2 Ulcers
7.2.1 Diabetic Foot Ulcers
7.2.2 Venous Ulcers
7.2.3 Pressure Ulcers
7.2.4 Other Ulcers
7.3 Surgical & Traumatic Wounds
7.4 Burns

8 Wound Care Biologics Market, By End User (Page No. – 58)
8.1 Introduction
8.2 Hospitals
8.3 Ambulatory Surgical Centers
8.4 Burn Centers and Wound Clinics

9 Wound Care Biologics Market, By Region (Page No. – 63)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 UK
9.3.2 Germany
9.3.3 France
9.3.4 RoE
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 90)
10.1 Overview
10.2 Market Share Ranking, 2017
10.3 Top Ranking Companies in the Wound Care Biologics Market
10.4 Wound Care Biologics Market Share Analysis in the Us, 2017
10.5 Competitive Scenario
10.5.1 Product Launches and Approvals
10.5.2 Agreements
10.5.3 Acquisitions
10.5.4 Expansions
10.5.5 Other Developments

11 Company Profiles (Page No. – 95)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Smith & Nephew
11.2 Mölnlycke Health Care AB (Investor AB)
11.3 Integra Lifesciences
11.4 Wright Medical
11.5 Mimedx Group
11.6 Vericel
11.7 Anika Therapeutics
11.8 Osiris Therapeutics
11.9 Organogenesis
11.10 Kerecis
11.11 Solsys Medical
11.12 Acell
11.13 Marine Polymer Technologies

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 116)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables (87 Tables)

Table 1 Major Skin Substitutes Available in the World Market
Table 2 Increase in Aging Population, By Region, 2015 vs 2050 (Million)
Table 3 Prevalence of Chronic Wounds in the Aging Population
Table 4 Age-Specific Prevalence of Diabetic Foot Ulcers, By Gender
Table 5 Prevalence of Diabetic Foot Ulcers, 2016
Table 6 List of Commercially Available Skin Substitutes, Their Indications, and Supporting Evidence for Use in Chronic Wounds
Table 7 Recently Launched Technologically Wound Care Biologics Products
Table 8 Awareness Initiatives Related to Wound Care Biologics
Table 9 Average Cost of Diabetic Foot Ulcer Management (Wagner Classification) in the Us
Table 10 Comparison of Outcomes (Stsg vs Ftsg Patients)
Table 11 Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 12 Biological Skin Substitutes Commercialized for Wound Treatment
Table 13 Wound Care Biologics Market for Skin Substitutes, By Region, 2016–2023 (USD Million)
Table 14 Wound Care Biologics Market for Biological Skin Substitutes, By Type, 2016–2023 (USD Million)
Table 15 Commercialized Human Donor Tissue-Derived Products
Table 16 Human Donor Tissue-Derived Products Market, By Region, 2016–2023 (USD Million)
Table 17 Commercialized Acellular Animal-Derived Products
Table 18 Acellular Animal-Derived Products Market, By Region, 2016–2023 (USD Million)
Table 19 Wound Care Biologics Market for Biosynthetic Products, By Region, 2016–2023 (USD Million)
Table 20 Wound Care Biologics Market for Topical Agents, By Region, 2016–2023 (USD Million)
Table 21 Common Components of Wound Care Biologics
Table 22 Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 23 Medically Necessary Bioengineered Skin Substitutes
Table 24 Wound Care Biologics Market for Ulcers, By Type, 2016–2023 (USD Million)
Table 25 Wound Care Biologics Market for Ulcers, By Region, 2016–2023 (USD Million)
Table 26 Prevalence Rate of Diabetic Foot Ulcers in Major Countries (2016)
Table 27 Average Treatment Cost for Diabetic Foot Ulcers in the US (2015)
Table 28 Wound Care Biologics Market for Diabetic Foot Ulcers, By Region, 2016–2023 (USD Million)
Table 29 Wound Care Biologics Market for Venous Ulcers, By Region, 2016–2023 (USD Million)
Table 30 Wound Care Biologics Market for Pressure Ulcers, By Region, 2016–2023 (USD Million)
Table 31 Commercially Available Wound Care Biologic Products for Other Ulcers
Table 32 Wound Care Biologics Market for Other Ulcers, By Region, 2016–2023 (USD Million)
Table 33 Wound Care Biologics Market for Surgical & Traumatic Wounds, By Region, 2016–2023 (USD Million)
Table 34 Average Hospital Admissions for the Treatment of Burn Injuries (2015)
Table 35 Skin Replacements Commercialized for the Treatment of Burns
Table 36 Wound Care Biologics Market for Burns, By Region, 2016–2023 (USD Million)
Table 37 Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 38 Wound Care Biologics Market for Hospitals, By Region, 2016–2023 (USD Million)
Table 39 Price Assessment of Wound Care Biologics in Ambulatory Surgical Centers in the Us
Table 40 Wound Care Biologics Market for Ambulatory Surgical Centers, By Region, 2016–2023 (USD Million)
Table 41 Wound Care Biologics Market for Burn Centers and Wound Clinics, By Region, 2016–2023 (USD Million)
Table 42 Wound Care Biologics Market, By Region, 2016–2023 (USD Million)
Table 43 North America: Wound Care Biologics Market, By Country, 2016–2023 (USD Million)
Table 44 North America: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 45 North America: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 46 North America: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 47 Major Skin Substitutes Launched in the Us
Table 48 US: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 49 US: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 50 US: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 51 Canada: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 52 Canada: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 53 Canada: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 54 Prevalence of Diabetes in Europe, 2015–2040
Table 55 Europe: Wound Care Biologics Market, By Country, 2016–2023 (USD Million)
Table 56 Europe: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 57 Europe: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 58 Europe: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 59 UK: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 60 UK: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 61 UK: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 62 Germany: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 63 Germany: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 64 Germany: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 65 France: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 66 France: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 67 France: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 68 RoE: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 69 RoE: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 70 RoE: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 71 APAC: Wound Care Biologics Market, By Country, 2016–2023 (USD Million)
Table 72 APAC: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 73 APAC: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 74 APAC: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 75 China: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 76 China: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 77 China: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 78 Japan: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 79 Japan: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 80 Japan: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 81 RoAPAC: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 82 RoAPAC: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 83 RoAPAC: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)
Table 84 RoW: Diabetic Population, By Region
Table 85 RoW: Wound Care Biologics Market, By Product, 2016–2023 (USD Million)
Table 86 RoW: Wound Care Biologics Market, By Wound Type, 2016–2023 (USD Million)
Table 87 RoW: Wound Care Biologics Market, By End User, 2016–2023 (USD Million)

List of Figures (32 Figures)

Figure 1 Global Wound Care Biologics Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Wound Care Biologics Market: Bottom-Up Approach
Figure 5 Wound Care Biologics Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Wound Care Biologics Market, By Product, 2018 vs 2023 (USD Billion)
Figure 8 Wound Care Biologics Market, By Wound Type, 2018 vs 2023 (USD Billion)
Figure 9 Wound Care Biologics Market, By End User, 2018 vs 2023 (USD Billion)
Figure 10 Wound Care Biologics Market, By Region, 2018 vs 2023 (USD Billion)
Figure 11 High Prevalence and Increasing Incidence Rate of Diabetic Foot Ulcers to Drive Market Growth
Figure 12 Biological Skin Substitutes to Dominate the North American Wound Care Biologics Market in 2018
Figure 13 Asia Pacific to Register the Highest CAGR During the Forecast Period
Figure 14 Biological Skin Substitutes to Dominate the Wound Care Biologics Market During 2018 to 2023
Figure 15 Wound Care Biologics Market: Drivers, Restraints, and Opportunities
Figure 16 Incidence of Diabetes, By Region (2015 vs 2040)
Figure 17 Biological Skin Substitute Segment to Witness the Highest Growth During the Forecast Period
Figure 18 Ulcers Segment to Witness the Highest Growth During the Forecast Period
Figure 19 Hospitals are Estimated to Be the Largest End Users of Wound Care Biologics in 2018
Figure 20 North America to Dominate the Wound Care Biologics Market in 2018
Figure 21 North America: Wound Care Biologics Market Snapshot
Figure 22 Wound Prevalence in the US (2013)
Figure 23 Asia Pacific : Wound Care Biologics Market Snapshot
Figure 24 Product Launches, the Most Adopted Growth Strategy From 2015 to 2018
Figure 25 Smith & Nephew: Company Snapshot
Figure 26 Mölnlycke Health Care AB (Investor AB): Company Snapshot
Figure 27 Integra Lifesciences: Company Snapshot
Figure 28 Wright Medical: Company Snapshot
Figure 29 Mimedx Group: Company Snapshot
Figure 30 Vericel: Company Snapshot
Figure 31 Anika Therapeutics: Company Snapshot
Figure 32 Osiris Therapeutics: Company Snapshot



【レポートのキーワード】

創傷ケア用生物製剤、生物学的代用皮膚、生合成製品、外用剤

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 創傷ケア用生物製剤の世界市場予測(~2023年):生物学的代用皮膚(生合成製品)、外用剤(Wound Care Biologics Market by Product (Biological Skin Substitutes (Biosynthetic Products), Topical Agents), Wound Type (Diabetic Foot Ulcer, Pressure Ulcers, Surgical & Traumatic Wound), End User (Hospitals, Burn Centers) - Global Forecast to 2023)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆